Timur Yur'EVich Danilov

Timur Yur'EVich Danilov

Auto-generated profile, based on publicly available information

Timur Yur'EVich Danilov

Bakulev National Medical Research Center of Cardiovascular Surgery

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 June 2026 in Complex Issues of Cardiovascular Diseases
Verified
Journal Article
Open access
PDF file
KPKaren V. Petrosyan
Karen V. Petrosyan
GDGulamjan M. Dadabaev
Gulamjan M. Dadabaev
KSKonstantin V. Shatalov
Konstantin V. Shatalov
TDTimur Yur'EVich Danilov
Timur Yur'EVich Danilov
BSBaizak A. Sagymbaev
Baizak A. Sagymbaev
EGElena Z. Golukhova
Elena Z. Golukhova
Highlights This study by the A.N. Bakulev NMRC of Cardiovascular Surgery reports for the first time in Russia on domestic clinical experience with transcatheter pulmonary valve implantation. Against the backdrop of the widespread adoption of this minimally invasive alternative to open surgery, the study provides a detailed analysis of the immediate results, efficacy, and safety of the technique at the A.N. Bakulev NMRC of Cardiovascular Surgery, which has performed the largest number of implants in the country.   Aim . Evaluation of the safety and efficacy of transcatheter pulmonary valve implantation in the 30-day postoperative period. Methods . A prospective single-center study included 55 patients aged 9 to 32 years (mean age 14.7 ± 3.36 years, male – 43 (78.2%)), operated on at the A.N. Bakulev National Medical Research Center of Cardiovascular Surgery in the period from June 2023 to November 2025 (1 patient – in 2008, assessed retrospectively). The most common initial diagnosis was tetralogy of Fallot (n = 29 (52.72%)). In 32 patients (58.18%), valve implantation was performed in the native right ventricular outflow tract (RVOT), 17 (30.91%) – in a conduit, 6 (10.91%) – in an allograft. In 9 cases (16.36%), implantation was performed into a stented conduit, in 3 cases (5.45%) – into a previously installed pulmonary valve prosthesis. The predominant pathophysiological mechanism was a combination of stenosis and regurgitation (56.37% (n = 31)); isolated pulmonary regurgitation was detected in 20 patients (36.36%), and isolated pulmonary valve stenosis was found in 4 patients (7.27%). The median lumen area in the implantation zone was 482.3 (279.1; 601.4) mm 2 . Results . Valves were implanted in all 55 (100%) patients. The following stent valves were implanted: 38 (69.1%) Myval, 13 (23.64%) Pulsta, 2 each (3.63%) VenusP-Valve and Melody. The median stent-valve diameters were 27.5 (23; 32) mm. The median intervention time was 85 (65; 135) min. The invasive RVOT systolic pressure gradient decreased from 15 (10; 29) to 9 (4; 15) mmHg after the surgery, and the noninvasive peak gradient decreased from 40 (26; 60) to 14 (8; 20) mmHg. Pulmonary regurgitation was eliminated or became minimal in 100% of patients. Technical success of the procedure was achieved in 94.5% (n = 52) of cases, and clinical success was achieved in 96.36% (n = 53). 3 (5.45%) complications occurred, 1 of which (1.82%) was intraoperative and required surgical stent removal (prestenting). There were no cases of valve displacement or dysfunction during the follow-up period, and the mortality rate was 0%. Conclusion . Transcatheter pulmonary valve implantation is an effective and safe alternative to repeated cardiac surgery in the treatment of patients who have underwent multi-stage surgical correction of congenital heart disease.

9 July 2026 in Siberian Journal of Clinical and Experimental Medicine
Verified
Journal Article
Closed access
MSM. I. Solovyova
M. I. Solovyova
AMAnton Minaev
Anton Minaev
IKI. A. Kovalev
I. A. Kovalev
ELE. V. Lyubkina
E. V. Lyubkina
OMO. I. Medvedeva
O. I. Medvedeva
TDT. Yu. Danilov
T. Yu. Danilov
Adult patients with congenital heart disease (ACHD) remain a poorly studied group in terms of arrhythmological complications, while at the same time representing one of the most actively investigated cohorts with arrhythmias today. Patients with a systemic right ventricle (sRV) after atrial switch operations or with congenitally corrected transposition of the great arteries are the most vulnerable subgroups in the congenital heart disease (CHD) population; however, specific criteria for sudden cardiac death (SCD) risk stratification in these patients are still lacking. This review summarizes current knowledge on the incidence and mechanisms of SCD, including the role of arrhythmogenic substrate, myocardial fibrosis, anatomical and physiological characteristics of the sRV, and the systemic atrioventricular valve. Data from national and international registries are presented, as well as recommendations for rhythm monitoring and detection of life-threatening arrhythmias, along with the latest risk stratification scores developed specifically for patients with sRV. The need for prolonged rhythm surveillance, refinement of indications for implantable cardioverter-defibrillators in primary prevention, and further research with registry data collection to optimize management strategies is emphasized.


10 October 2026 in Terapevticheskii arkhiv
Verified
Journal Article
Open access
PDF file
EGElena Z. Golukhova
Elena Z. Golukhova
ГЗГолухова Елена Зеликовна
Голухова Елена Зеликовна
MMMarina Yu. Mironenko
Marina Yu. Mironenko
МЮМироненко Марина Юрьевна
Мироненко Марина Юрьевна
AMAnton Minaev
Anton Minaev
СБСамсонов Виктор Борисович
Самсонов Виктор Борисович
Aim. To compare myocardial deformation indicators between the left (LA) and right atria (RA) using speckle tracking echocardiography in adult patients with septal defects and to identify parameters associated with the atrial fibrillation (AF). Materials and methods. A prospective study conducted from 2022 to 2025 included 120 patients with congenital heart disease and left-to-right blood shunting (mean age 51.0±13.1 years). The congenital heart defects in the cohort included atrial septal defect in 82.5% (n=99), partial anomalous pulmonary vein drainage with atrial septal defect in 11.7% (n=14), and partial atrioventricular canal in 5.8% (n=7); in all cases, a significant arteriovenous shunt was observed. Paroxysmal AF was diagnosed in 29.8% of patients. Results. Notable RA dilation was observed with indexed RA volume of 49.9±18 mL/m2, while the indexed LA volume was borderline at 32.6±12.4 mL/m2, showing a significant difference between the two (p0.001). Additionally, deformation parameters during the contraction phase also differed significantly (p0.002). Moderate to strong correlations were established between the volumetric and deformation parameters of both chambers. The independent predictors of AF, identified through multivariate analysis, included the left atrial volume index (LAVI) (odds ratio 1.098, 95% confidence interval 1.029–1.171; p=0.005) and the estimated right ventricular systolic pressure (eRVSP) (odds ratio 1.080, 95% confidence interval 1.004–1.163; p=0.040). Conclusion. Morphofunctional changes associated with septal defects are characteristic of both RA and LA. LAVI and eRVSP are independent predictors of AF development, highlighting the importance of a comprehensive assessment of both the right and left heart chambers.